相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The emerging role of measurable residual disease detection in AML in morphologic remission
F. Buccisano et al.
SEMINARS IN HEMATOLOGY (2019)
Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia
Mary-Elizabeth M. Percival et al.
CANCER (2019)
Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis
Grzegorz Helbig et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
Comparison of clinical remission and survival between CLAG and FLAG induction chemotherapy in patients with refractory or relapsed acute myeloid leukemia: a prospective cohort study
Y. Bao et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission
F. Saraceni et al.
BONE MARROW TRANSPLANTATION (2017)
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years
Alexander D. Heini et al.
LEUKEMIA RESEARCH (2017)
Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary acute myeloid leukemia in first remission
Jianfeng Yao et al.
LEUKEMIA RESEARCH (2017)
Autologous hematopoietic stem cell transplantation for acute myeloid leukemia - single center experience
I. Simancikova et al.
NEOPLASMA (2017)
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
Matthew P. Mule et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR
M. Mizutani et al.
BONE MARROW TRANSPLANTATION (2016)
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Nestor R. Ramos et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Revisiting the role of cladribine in acute myeloid leukemia: An improvement on past accomplishments or more old news?
Craig W. Freyer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years
J. J. Cornelissen et al.
LEUKEMIA (2015)
Cladribine in the treatment of acute myeloid leukemia
Tadeusz Robak et al.
LEUKEMIA RESEARCH (2014)
Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research
Armand Keating et al.
HAEMATOLOGICA (2013)
Comparison of Autologous Hematopoietic Cell Transplantation and Chemotherapy as Postremission Treatment in Non-M3 Acute Myeloid Leukemia in First Complete Remission
Kensuke Usuki et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2012)
Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study
Jerzy Holowiecki et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
Edo Vellenga et al.
BLOOD (2011)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
分享论文
